Nexalin Technology (NXL) Equity Average (2021 - 2026)

Nexalin Technology has reported Equity Average for 6 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 10.54% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 10.54% YoY), and the FY2025 full-year result was $3.7 million, up 7.87% from the prior year.
• Equity Average for Q1 2026 stood at $3.3 million, down from $4.3 million in the prior quarter.
• The five-year high for Equity Average was $5.9 million in Q4 2022, with the low at -$2.1 million in Q2 2022.
• Average Equity Average over 5 years is $3.1 million, with a median of $3.3 million recorded in 2026.
• Year-over-year, Equity Average jumped 424.18% in 2022 and sank 57.86% in 2024.
• Tracing NXL's Equity Average over 5 years: stood at $5.9 million in 2022, then slumped by 45.55% to $3.2 million in 2023, then jumped by 34.0% to $4.3 million in 2024, then fell by 1.36% to $4.3 million in 2025, then decreased by 22.1% to $3.3 million in 2026.
• The last three Equity Average figures came in at $3.3 million (Q1 2026), $4.3 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.

Peer Comparison